• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Great Post on BMS Board

Anonymous

Guest
Re: Eliquis launch comment

--------------------------------------------------------------------------------

This single launch did two things:

1. Highlight BMS' inability to sell
2. Put to death the myth that Pfizer reps are great

Single best drug for each company in over a decade, best in class data, last in class usage.

Pitiful.
 




Re: Eliquis launch comment

--------------------------------------------------------------------------------

This single launch did two things:

1. Highlight BMS' inability to sell
2. Put to death the myth that Pfizer reps are great

Single best drug for each company in over a decade, best in class data, last in class usage.

Pitiful.

We'll see who the pitiful one truly is, once Pradaxa is forced to withdraw from the market.

Dumbass.